首页 > 最新文献

Taiwan Journal of Ophthalmology最新文献

英文 中文
Anterior lamellar recession versus bilamellar tarsal rotation in upper lid cicatricial trichiasis. 上睑瘢痕倒睫中前板层后退与双层跗骨旋转
IF 1.1 Q4 OPHTHALMOLOGY Pub Date : 2023-05-16 eCollection Date: 2023-07-01 DOI: 10.4103/tjo.TJO-D-22-00170
Ezzeldin Ramadan Ezzeldin, Akram Fekry Elgazzar, Mostafa Osman Hussein, Ezzat Nabil Abbas Ibrahim, Ehab Tharwat

Purpose: In recent years, there has been a significant shift from this destructive procedure to a reconstructive procedure such as anterior lamellar recession (ALR) and bilamellar tarsal rotation (BLTR). The aim is to report the outcomes and success rates of ALR compared to BLTR in patients with upper lid cicatricial trichiasis.

Materials and methods: Our study is a prospective, interventional, comparative study that was conducted at the Ophthalmology Department of Al-Azhar University Hospital, New Damietta, Egypt. Our study was conducted on 62 eyes of 45 consecutive patients suffering from upper lid cicatricial trichiasis that required surgical intervention (17 patients were bilateral and 28 were unilateral). Thirty-three of them were treated by ALR (group 1), and 29 of them by BLTR (group 2). All statistical analysis was performed using the SPSS version 26.

Results: As regards the immediate postoperative correction, we found that adequate correction was significantly higher in the ALR group at all follow-up periods (P < 0.05). However, the overcorrection and undercorrection were significantly higher in the BLTR group (P < 0.05). Compared to the ALR group, the BLTR group saw a greater undercorrection at 1, 3, and 6 months (9.3%% vs. 0%; P = 0.048, 18.6% vs. 1.8%%; P = 0.009, 18.6%% vs. 1.8%; P = 0.009, 18.6%% vs. 1.8%; P = 0.009, respectively).

Conclusion: ALR is better than BLTR in the treatment of upper lid cicatricial trichiasis.

目的:近年来,从这种破坏性手术到重建手术的重大转变,如前板层退缩(ALR)和双板层跗骨旋转(BLTR)。目的是报告与BLTR相比,ALR治疗上眼睑瘢痕性倒睫的疗效和成功率。材料和方法:我们的研究是在埃及新达米埃塔爱资哈尔大学医院眼科进行的一项前瞻性、介入性、比较性研究。我们的研究对象是连续45例62只眼的上眼睑瘢痕性倒睫患者,需要手术治疗(17例为双侧,28例为单侧)。ALR治疗33例(1组),BLTR治疗29例(2组)。统计学分析采用SPSS 26版。结果:在术后立即矫正方面,我们发现在所有随访期间,ALR组的矫正率明显高于ALR组(P < 0.05)。而BLTR组的过矫治和欠矫治发生率明显高于对照组(P < 0.05)。与ALR组相比,BLTR组在1、3和6个月时出现了更大的矫正不足(9.3%比0%;P = 0.048, 18.6% vs. 1.8%;P = 0.009, 18.6% vs. 1.8%;P = 0.009, 18.6% vs. 1.8%;P = 0.009)。结论:ALR治疗上睑瘢痕性倒睫优于BLTR。
{"title":"Anterior lamellar recession versus bilamellar tarsal rotation in upper lid cicatricial trichiasis.","authors":"Ezzeldin Ramadan Ezzeldin, Akram Fekry Elgazzar, Mostafa Osman Hussein, Ezzat Nabil Abbas Ibrahim, Ehab Tharwat","doi":"10.4103/tjo.TJO-D-22-00170","DOIUrl":"10.4103/tjo.TJO-D-22-00170","url":null,"abstract":"<p><strong>Purpose: </strong>In recent years, there has been a significant shift from this destructive procedure to a reconstructive procedure such as anterior lamellar recession (ALR) and bilamellar tarsal rotation (BLTR). The aim is to report the outcomes and success rates of ALR compared to BLTR in patients with upper lid cicatricial trichiasis.</p><p><strong>Materials and methods: </strong>Our study is a prospective, interventional, comparative study that was conducted at the Ophthalmology Department of Al-Azhar University Hospital, New Damietta, Egypt. Our study was conducted on 62 eyes of 45 consecutive patients suffering from upper lid cicatricial trichiasis that required surgical intervention (17 patients were bilateral and 28 were unilateral). Thirty-three of them were treated by ALR (group 1), and 29 of them by BLTR (group 2). All statistical analysis was performed using the SPSS version 26.</p><p><strong>Results: </strong>As regards the immediate postoperative correction, we found that adequate correction was significantly higher in the ALR group at all follow-up periods (<i>P</i> < 0.05). However, the overcorrection and undercorrection were significantly higher in the BLTR group (<i>P</i> < 0.05). Compared to the ALR group, the BLTR group saw a greater undercorrection at 1, 3, and 6 months (9.3%% vs. 0%; <i>P</i> = 0.048, 18.6% vs. 1.8%%; <i>P</i> = 0.009, 18.6%% vs. 1.8%; <i>P</i> = 0.009, 18.6%% vs. 1.8%; <i>P</i> = 0.009, respectively).</p><p><strong>Conclusion: </strong>ALR is better than BLTR in the treatment of upper lid cicatricial trichiasis.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 1","pages":"329-334"},"PeriodicalIF":1.1,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712740/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45488518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An unusual coexistence of iris mammillations and optic disc pit with keratoconus: A case report and literature review. 虹膜乳突和视盘凹陷与角膜炎并存的不寻常现象:病例报告和文献综述。
IF 1.1 Q4 OPHTHALMOLOGY Pub Date : 2023-05-16 eCollection Date: 2024-01-01 DOI: 10.4103/tjo.TJO-D-22-00148
Hamzeh Mohammad Alrawashdeh

Iris mammillations are distinctive uniform nipple-like elevations that cover the anterior surface of the iris partially or totally. It is a rare finding and may coexist with other ocular and extraocular manifestations. Optic nerve pit (ONP), also known as optic disc pit (ODP) or optic hole, is a congenital defect resulting from the failure of fetal fissure closure during the embryonic development. It belongs to the congenital cavitary anomalies spectrum. This case presents a 19-year-old female patient who complained of a gradual decrease in visual acuity in both eyes for 4 years. Slit-lamp and fundus examinations revealed iris mammillations and ODP in the left eye. Corneal topography revealed bilateral keratoconus, which was managed with cross-linking. Iris mammillations and ODP are poorly understood ocular anomalies that are not reported frequently and have never been reported previously both combined with keratoconus. Thus, ophthalmologists should be aware of these conditions, their differential diagnosis, and their possible association with other disorders. This is the first reported case of the combined coexistence of iris mammillations and ODP with keratoconus.

虹膜乳突是一种明显的均匀乳头状隆起,部分或全部覆盖虹膜前表面。这是一种罕见的病变,可能与其他眼部和眼外表现同时存在。视神经凹陷(ONP)又称视盘凹陷(ODP)或视洞,是胚胎发育过程中胎儿裂隙闭合失败导致的先天性缺陷。它属于先天性腔隙畸形。本病例中的患者是一名 19 岁的女性,主诉双眼视力逐渐下降已有 4 年之久。裂隙灯和眼底检查发现左眼虹膜乳突和 ODP。角膜地形图显示患者患有双侧角膜炎,已通过角膜交联术进行了治疗。虹膜乳突和ODP是人们对眼部异常了解甚少的病症,并不经常被报道,以前也从未有过同时合并角膜屈光不正的报道。因此,眼科医生应该了解这些情况、它们的鉴别诊断以及与其他疾病的可能关联。这是第一例虹膜乳头状瘤和 ODP 与角膜炎同时存在的病例。
{"title":"An unusual coexistence of iris mammillations and optic disc pit with keratoconus: A case report and literature review.","authors":"Hamzeh Mohammad Alrawashdeh","doi":"10.4103/tjo.TJO-D-22-00148","DOIUrl":"10.4103/tjo.TJO-D-22-00148","url":null,"abstract":"<p><p>Iris mammillations are distinctive uniform nipple-like elevations that cover the anterior surface of the iris partially or totally. It is a rare finding and may coexist with other ocular and extraocular manifestations. Optic nerve pit (ONP), also known as optic disc pit (ODP) or optic hole, is a congenital defect resulting from the failure of fetal fissure closure during the embryonic development. It belongs to the congenital cavitary anomalies spectrum. This case presents a 19-year-old female patient who complained of a gradual decrease in visual acuity in both eyes for 4 years. Slit-lamp and fundus examinations revealed iris mammillations and ODP in the left eye. Corneal topography revealed bilateral keratoconus, which was managed with cross-linking. Iris mammillations and ODP are poorly understood ocular anomalies that are not reported frequently and have never been reported previously both combined with keratoconus. Thus, ophthalmologists should be aware of these conditions, their differential diagnosis, and their possible association with other disorders. This is the first reported case of the combined coexistence of iris mammillations and ODP with keratoconus.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"125-128"},"PeriodicalIF":1.1,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11034683/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic testing confirmed osteopetrosis with initial presentation of nystagmus. 基因检测证实他患有骨营养不良症,最初表现为眼球震颤。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2023-04-28 eCollection Date: 2024-07-01 DOI: 10.4103/tjo.TJO-D-22-00152
Kai-Yen Chiu, Yu-Yang Lin, Yao-Lin Liu, Ni-Chung Lee, Tzu-Hsun Tsai

Osteopetrosis (OS) is a rare heritable disorder characterized by osteoclast dysfunction and increased bone density on radiography. Optic nerve osseous compression is the most frequent ocular complication of OS, with nystagmus, strabismus, ptosis, proptosis, and lagophthalmos occurring less frequently. However, it is uncommon for patients to have neurological or ocular symptoms at initial presentation. Herein, we present the case of a 3-year-old girl with the initial presentation of ocular symptoms who was confirmed to have OS through genetic testing. She was born full-term and found to have nystagmus since the age of 1 year. Her best-corrected visual acuity was 1.2/60 for both eyes. Exotropia of the left eye and bilateral small-amplitude pendular nystagmus were also noted. Color fundoscopy revealed a tessellated fundus and pale discs with cup-to-disc ratios of 0.5-0.6. Magnetic resonance imaging revealed bilateral optic canal stenosis and optic nerve atrophy. Whole-exome sequencing revealed a biallelic chloride voltage-gated channel 7 mutation, c.2297T > C (p.Leu766Pro) and c.1577G > A (p.Arg526Gln), and autosomal recessive OS was diagnosed. The patient is currently being evaluated for possible hematopoietic stem cell transplantation. We suggest that OS should be considered a differential diagnosis for unexplained nystagmus and optic nerve atrophy.

骨化症(Osteopetrosis,OS)是一种罕见的遗传性疾病,其特征是破骨细胞功能障碍和骨密度增高。视神经骨质受压是OS最常见的眼部并发症,眼球震颤、斜视、上睑下垂、眼球突出和眼睑下垂则较少发生。然而,患者最初出现神经系统或眼部症状的情况并不多见。在此,我们介绍一例最初表现为眼部症状的 3 岁女孩,她通过基因检测被确诊为 OS 患者。她足月出生,1 岁时发现眼球震颤。她的双眼最佳矫正视力为 1.2/60。同时还发现左眼外斜和双侧小振幅下垂性眼球震颤。彩色眼底镜检查显示,眼底呈棋盘格状,视盘苍白,杯盘比为 0.5-0.6。磁共振成像显示双侧视管狭窄和视神经萎缩。全外显子组测序结果显示,患者的氯离子电压门控通道7发生了c.2297T > C(p.Leu766Pro)和c.1577G > A(p.Arg526Gln)的双拷贝突变,确诊为常染色体隐性遗传性视神经萎缩症。目前正在对患者进行评估,以确定是否进行造血干细胞移植。我们建议将 OS 作为不明原因眼球震颤和视神经萎缩的鉴别诊断。
{"title":"Genetic testing confirmed osteopetrosis with initial presentation of nystagmus.","authors":"Kai-Yen Chiu, Yu-Yang Lin, Yao-Lin Liu, Ni-Chung Lee, Tzu-Hsun Tsai","doi":"10.4103/tjo.TJO-D-22-00152","DOIUrl":"10.4103/tjo.TJO-D-22-00152","url":null,"abstract":"<p><p>Osteopetrosis (OS) is a rare heritable disorder characterized by osteoclast dysfunction and increased bone density on radiography. Optic nerve osseous compression is the most frequent ocular complication of OS, with nystagmus, strabismus, ptosis, proptosis, and lagophthalmos occurring less frequently. However, it is uncommon for patients to have neurological or ocular symptoms at initial presentation. Herein, we present the case of a 3-year-old girl with the initial presentation of ocular symptoms who was confirmed to have OS through genetic testing. She was born full-term and found to have nystagmus since the age of 1 year. Her best-corrected visual acuity was 1.2/60 for both eyes. Exotropia of the left eye and bilateral small-amplitude pendular nystagmus were also noted. Color fundoscopy revealed a tessellated fundus and pale discs with cup-to-disc ratios of 0.5-0.6. Magnetic resonance imaging revealed bilateral optic canal stenosis and optic nerve atrophy. Whole-exome sequencing revealed a biallelic chloride voltage-gated channel 7 mutation, c.2297T > C (p.Leu766Pro) and c.1577G > A (p.Arg526Gln), and autosomal recessive OS was diagnosed. The patient is currently being evaluated for possible hematopoietic stem cell transplantation. We suggest that OS should be considered a differential diagnosis for unexplained nystagmus and optic nerve atrophy.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"437-440"},"PeriodicalIF":1.0,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11488795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intra-arterial chemotherapy for retinoblastoma: Experience from the pediatric ophthalmology referral center in Malaysia with literature review. 视网膜母细胞瘤的动脉内化疗:马来西亚儿童眼科转诊中心的经验及文献综述。
IF 1.1 Q4 OPHTHALMOLOGY Pub Date : 2023-04-28 eCollection Date: 2023-10-01 DOI: 10.4103/tjo.TJO-D-22-00162
Yong Zheng Wai, Dhanya Menon Radhakrishnan, Ganeshwara Lingam, Norhafizah Hamzah, Jamalia Rahmat

Purpose: We aimed to analyze our 4-year experience of intra-arterial chemotherapy (IAC) for retinoblastoma (RB) and to examine the tumor response, globe salvage, mortality, and safety profile of IAC in the Malaysian profile.

Materials and methods: This was a retrospective, interventional case series. A total of 22 eyes of 20 patients with RB who underwent IAC using melphalan and topotecan from January 2018 to December 2021 in Hospital Kuala Lumpur were retrospectively reviewed. Tumor response, globe salvage, mortality, and safety profile of IAC were compared based on the International Classification of Retinoblastoma.

Results: The mean patient age at IAC was 21.3 months. An overall globe salvage rate of 63.6% was observed: more specifically, 100% for Group A, 75% for Groups B and C, 66.7% for Group D, and 42.9% for Group E. Poor tumor response after IAC was significantly associated with a lesser chance of globe salvage (P = 0.045). The overall rate of good tumor response following IAC was 77.3%. Specifically, rates of good tumor response in each group were 100%, 75%, 75%, 83.3% and 71.4% in group A, B, C, D and E, respectively. The mortality rate was 5%. Complications (per-catheterization) included cerebral infarct (2.2%), oxygen desaturation (2.2%), vomiting (26.1%), periorbital edema (8.8%), ptosis (6.5%), fever, femoral hematoma, and hyperpigmentation over lid (4.4% each).

Conclusion: Four-year experience showed that IAC is a safe and effective method for RB management. Patients with a poor response after IAC may have a lower chance of globe salvage. Careful patient selection is of utmost importance to achieve the best outcome in a setting of limited health-care resources.

目的:我们旨在分析我们对视网膜母细胞瘤(RB)进行动脉内化疗(IAC)的4年经验,并研究马来西亚IAC的肿瘤反应、全球挽救率、死亡率和安全性概况:这是一项回顾性介入病例系列研究。回顾性分析了2018年1月至2021年12月在吉隆坡医院使用美法仑和托泊替康接受IAC治疗的20名RB患者的22只眼睛。根据视网膜母细胞瘤国际分类比较了IAC的肿瘤反应、球部挽救、死亡率和安全性:结果:接受IAC治疗的患者平均年龄为21.3个月。IAC术后肿瘤反应差与眼球挽救率低显著相关(P = 0.045)。IAC 术后肿瘤反应良好的总比率为 77.3%。具体来说,A、B、C、D 和 E 组的肿瘤良好反应率分别为 100%、75%、75%、83.3% 和 71.4%。死亡率为 5%。并发症(导管插入后)包括脑梗塞(2.2%)、氧饱和度下降(2.2%)、呕吐(26.1%)、眶周水肿(8.8%)、眼睑下垂(6.5%)、发热、股骨头血肿和睑部色素沉着(各占 4.4%):四年的经验表明,IAC是一种安全有效的RB治疗方法。结论:四年的经验表明,IAC是治疗RB的一种安全有效的方法。在医疗资源有限的情况下,谨慎选择患者以获得最佳疗效至关重要。
{"title":"Intra-arterial chemotherapy for retinoblastoma: Experience from the pediatric ophthalmology referral center in Malaysia with literature review.","authors":"Yong Zheng Wai, Dhanya Menon Radhakrishnan, Ganeshwara Lingam, Norhafizah Hamzah, Jamalia Rahmat","doi":"10.4103/tjo.TJO-D-22-00162","DOIUrl":"10.4103/tjo.TJO-D-22-00162","url":null,"abstract":"<p><strong>Purpose: </strong>We aimed to analyze our 4-year experience of intra-arterial chemotherapy (IAC) for retinoblastoma (RB) and to examine the tumor response, globe salvage, mortality, and safety profile of IAC in the Malaysian profile.</p><p><strong>Materials and methods: </strong>This was a retrospective, interventional case series. A total of 22 eyes of 20 patients with RB who underwent IAC using melphalan and topotecan from January 2018 to December 2021 in Hospital Kuala Lumpur were retrospectively reviewed. Tumor response, globe salvage, mortality, and safety profile of IAC were compared based on the International Classification of Retinoblastoma.</p><p><strong>Results: </strong>The mean patient age at IAC was 21.3 months. An overall globe salvage rate of 63.6% was observed: more specifically, 100% for Group A, 75% for Groups B and C, 66.7% for Group D, and 42.9% for Group E. Poor tumor response after IAC was significantly associated with a lesser chance of globe salvage (<i>P</i> = 0.045). The overall rate of good tumor response following IAC was 77.3%. Specifically, rates of good tumor response in each group were 100%, 75%, 75%, 83.3% and 71.4% in group A, B, C, D and E, respectively. The mortality rate was 5%. Complications (per-catheterization) included cerebral infarct (2.2%), oxygen desaturation (2.2%), vomiting (26.1%), periorbital edema (8.8%), ptosis (6.5%), fever, femoral hematoma, and hyperpigmentation over lid (4.4% each).</p><p><strong>Conclusion: </strong>Four-year experience showed that IAC is a safe and effective method for RB management. Patients with a poor response after IAC may have a lower chance of globe salvage. Careful patient selection is of utmost importance to achieve the best outcome in a setting of limited health-care resources.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"527-534"},"PeriodicalIF":1.1,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10798403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The art of fixing a ticking time bomb: Combined phacoemulsification and amniotic membrane transplantation. 修复定时炸弹的艺术:联合超声乳化术和羊膜移植术。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2023-04-26 eCollection Date: 2024-04-01 DOI: 10.4103/tjo.TJO-D-23-00009
Allan Chong-Su Tang, Swee Sew Teh, Geng-Yi Yong, Zhi-Han Tan, Xiu-Rong Yong

Bleb leakage is a notorious complication of glaucoma filtration surgery which increases the risk of sight-threatening conditions. A 25-year-old female with severe bilateral juvenile open-angle glaucoma was treated for blebitis and exogenous endophthalmitis secondary to chronic bleb leak after undergoing XEN implantation, followed by multiple rounds of bleb needling, and augmented trabeculectomy. In the right eye, visual acuity was hand movement with cataract, intraocular pressure was 6 mmHg and the bleb was large, highly elevated from 10 to 1 o'clock, avascular, thin wall, and cystic with leaking points. Combined surgery of low-setting phacoemulsification and amniotic membrane transplantation without excising and manipulating the bleb was performed in the same setting. At postoperative 1 month, 6 months, and 1 year, her right vision had improved to 6/24, and the intraocular pressure was 12-14 mmHg, and the bleb leakage had resolved. This successful treatment was accomplished by maintaining the bleb's viability, preventing additional injury, and promoting wound healing.

眼泡渗漏是青光眼滤过手术中一种臭名昭著的并发症,会增加危及视力的风险。一名 25 岁女性患者患有严重的双侧青少年开角型青光眼,在接受 XEN 植入术、多轮眼泡针刺术和增强型小梁切除术后,因慢性眼泡漏继发眼泡炎和外源性眼内炎而接受了治疗。右眼视力为手部活动,伴有白内障,眼压为 6 mmHg,眼泡较大,从 10 点钟到 1 点钟高度隆起,无血管,壁薄,有囊性渗漏点。在同样的情况下,进行了低位乳化联合羊膜移植手术,但没有切除和处理眼泡。术后1个月、6个月和1年时,她的右眼视力已提高到6/24,眼压为12-14 mmHg,眼泡渗漏也已消除。这次成功的治疗是通过维持眼泡的活力、防止额外损伤和促进伤口愈合实现的。
{"title":"The art of fixing a ticking time bomb: Combined phacoemulsification and amniotic membrane transplantation.","authors":"Allan Chong-Su Tang, Swee Sew Teh, Geng-Yi Yong, Zhi-Han Tan, Xiu-Rong Yong","doi":"10.4103/tjo.TJO-D-23-00009","DOIUrl":"10.4103/tjo.TJO-D-23-00009","url":null,"abstract":"<p><p>Bleb leakage is a notorious complication of glaucoma filtration surgery which increases the risk of sight-threatening conditions. A 25-year-old female with severe bilateral juvenile open-angle glaucoma was treated for blebitis and exogenous endophthalmitis secondary to chronic bleb leak after undergoing XEN implantation, followed by multiple rounds of bleb needling, and augmented trabeculectomy. In the right eye, visual acuity was hand movement with cataract, intraocular pressure was 6 mmHg and the bleb was large, highly elevated from 10 to 1 o'clock, avascular, thin wall, and cystic with leaking points. Combined surgery of low-setting phacoemulsification and amniotic membrane transplantation without excising and manipulating the bleb was performed in the same setting. At postoperative 1 month, 6 months, and 1 year, her right vision had improved to 6/24, and the intraocular pressure was 12-14 mmHg, and the bleb leakage had resolved. This successful treatment was accomplished by maintaining the bleb's viability, preventing additional injury, and promoting wound healing.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"275-278"},"PeriodicalIF":1.0,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11253997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral optic disc edema and serous retinal detachment as initial ocular manifestations of systemic lymphoma: A case report and literature review. 双侧视盘水肿和浆液性视网膜脱离是全身性淋巴瘤的最初眼部表现:病例报告和文献综述。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2023-04-20 eCollection Date: 2024-07-01 DOI: 10.4103/tjo.TJO-D-22-00176
Chi-Yeh Wu, Chun-Chen Chen, Shiow-Wen Liou, Ju-Chuan Yen

This report describes a unique case of systemic diffuse large B-cell lymphoma (DLBCL) with initial ocular manifestations of bilateral optic disc edema and serous retinal detachment (SRD). A 29-year-old man presented with altered color vision in the left eye, mild fever, weakness, and headache, followed by bilaterally reduced visual acuity. Anterior segment and vitreous examinations showed no inflammation with sluggish response of light reflex. His fundus examination revealed bilateral multiple SRDs and optic disc swelling with choroidal thickening. On fluorescein angiography, pinpoint hyperfluorescence, associated dye pooling, and optic disc staining with leakage were found bilaterally. Laboratory studies revealed elevated C-reactive protein and mild leukocytosis with neutrophil predominance. He was provisionally diagnosed with probable Vogt-Koyanagi-Harada syndrome and received methylprednisolone pulse therapy. Five days later, his systemic condition deteriorated following initial ocular symptom improvement. Whole-body computerized tomography revealed clustered lymphadenopathies, which were interpreted as DLBCL after lymph node biopsy. His ocular condition improved after DLBCL chemotherapy. We hope to promote early recognition with appropriate workups through this case and literature review.

本报告描述了一例独特的全身性弥漫大 B 细胞淋巴瘤(DLBCL)病例,其最初的眼部表现为双侧视盘水肿和浆液性视网膜脱离(SRD)。一名29岁的男子因左眼色觉改变、轻度发热、乏力和头痛就诊,随后出现双侧视力下降。眼前节和玻璃体检查显示没有炎症,光反射反应迟钝。他的眼底检查显示双侧多发性色素沉着,视盘肿胀,脉络膜增厚。在荧光素血管造影检查中,发现双侧有针尖状高荧光、伴有染料汇集和视盘染色渗漏。实验室检查显示,C 反应蛋白升高,白细胞轻度增多,中性粒细胞占优势。他被初步诊断为可能患有 Vogt-Koyanagi-Harada 综合征,并接受了甲基强的松龙脉冲治疗。五天后,在最初的眼部症状改善后,他的全身状况恶化。全身计算机断层扫描发现了簇状淋巴结病变,淋巴结活检后被解释为 DLBCL。DLBCL 化疗后,他的眼部症状有所改善。我们希望通过本病例和文献回顾,促进早期识别和适当检查。
{"title":"Bilateral optic disc edema and serous retinal detachment as initial ocular manifestations of systemic lymphoma: A case report and literature review.","authors":"Chi-Yeh Wu, Chun-Chen Chen, Shiow-Wen Liou, Ju-Chuan Yen","doi":"10.4103/tjo.TJO-D-22-00176","DOIUrl":"10.4103/tjo.TJO-D-22-00176","url":null,"abstract":"<p><p>This report describes a unique case of systemic diffuse large B-cell lymphoma (DLBCL) with initial ocular manifestations of bilateral optic disc edema and serous retinal detachment (SRD). A 29-year-old man presented with altered color vision in the left eye, mild fever, weakness, and headache, followed by bilaterally reduced visual acuity. Anterior segment and vitreous examinations showed no inflammation with sluggish response of light reflex. His fundus examination revealed bilateral multiple SRDs and optic disc swelling with choroidal thickening. On fluorescein angiography, pinpoint hyperfluorescence, associated dye pooling, and optic disc staining with leakage were found bilaterally. Laboratory studies revealed elevated C-reactive protein and mild leukocytosis with neutrophil predominance. He was provisionally diagnosed with probable Vogt-Koyanagi-Harada syndrome and received methylprednisolone pulse therapy. Five days later, his systemic condition deteriorated following initial ocular symptom improvement. Whole-body computerized tomography revealed clustered lymphadenopathies, which were interpreted as DLBCL after lymph node biopsy. His ocular condition improved after DLBCL chemotherapy. We hope to promote early recognition with appropriate workups through this case and literature review.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"448-453"},"PeriodicalIF":1.0,"publicationDate":"2023-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11488802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripheral ulcerative keratitis secondary to chronic Citrobacter koseri canaliculitis. 继发于慢性柯氏柠檬酸杆菌小管炎的外周溃疡性角膜炎
IF 1.1 Q4 OPHTHALMOLOGY Pub Date : 2023-04-17 eCollection Date: 2023-07-01 DOI: 10.4103/tjo.TJO-D-22-00144
Hsiu-Hui Hsieh, Elizabeth P Shen

Citrobacter koseri is a rarely reported ocular pathogen. It may induce severe peripheral corneal inflammation and subsequent perforation by canaliculitis. Timely detection of the reservoir of this pathogen would halt its progression. The purpose of this study was to report a rare presentation of C. koseri chronic canaliculitis complicated with perforating peripheral ulcerative keratitis (PUK). A 71-year-old female who had several episodes of C. koseri conjunctivitis in the past 6 months was admitted to our infection ward under the impression of fever that was suspected to be related to urinary tract infection. She had concurrent copious mucopurulent discharge and blurred vision. Ocular examination disclosed hyperemic conjunctiva and an oval-shaped corneal infiltrate at 5-6 o'c periphery, which later rapidly progressed to PUK and corneal perforation. Despite aggressive treatment, the cornea continued to thin, and a second perforation occurred. After meticulous examination of the ocular adnexa, irrigation of inferior canaliculi revealed pustular discharge with profuse concretions indicating chronic canaliculitis. A cutaneous-lacrimal fistula was also found. Frequent antibiotic irrigation of the canaliculus finally halted the corneal melting and the cornea healed. Although rare, C. koseri may not only cause chronic canaliculitis but also induce peripheral corneal inflammation mimicking autoimmune-related PUK. Identification of C. koseri from conjunctival swab cultures should prompt the physicians to check chronic persistent canaliculus infections, which may help prevent rapidly progressive corneal inflammation and thus perforation. Management of C. koseri canaliculitis-induced PUK must also include antibiotic irrigation to eradicate canaliculitis infection at the reservoir and not just topical antibiotics.

柯氏柠檬酸杆菌是一种罕见的眼部病原菌。它可能引起严重的角膜周围炎症和随后的小管炎穿孔。及时发现这种病原体的储存库将阻止其发展。本研究的目的是报道一罕见的C. koseri慢性小管炎合并穿孔周围性溃疡性角膜炎(PUK)。一名71岁女性患者于过去6个月内多次发生克氏梭菌结膜炎,因发热疑似与尿路感染有关而入住感染病房。她同时有大量粘液脓性分泌物和视力模糊。眼部检查发现结膜充血和5-6°外周卵圆形角膜浸润,随后迅速发展为PUK和角膜穿孔。尽管积极治疗,角膜继续变薄,并发生第二次穿孔。仔细检查眼附件后,冲洗下小管,发现脓疱性分泌物伴大量结块,提示慢性小管炎。皮肤-泪瘘也被发现。频繁的抗生素小管冲洗最终阻止了角膜融化,角膜愈合。虽然罕见,但C. koseri不仅可以引起慢性小管炎,还可以诱导角膜周围炎症,模拟自身免疫相关的PUK。从结膜拭子培养中鉴定出克氏梭菌应提示医生检查慢性持续性小管感染,这可能有助于预防迅速进展的角膜炎症和穿孔。处理克氏梭菌小管炎引起的PUK还必须包括抗生素冲洗以根除水库小管炎感染,而不仅仅是局部抗生素。
{"title":"Peripheral ulcerative keratitis secondary to chronic <i>Citrobacter koseri</i> canaliculitis.","authors":"Hsiu-Hui Hsieh, Elizabeth P Shen","doi":"10.4103/tjo.TJO-D-22-00144","DOIUrl":"10.4103/tjo.TJO-D-22-00144","url":null,"abstract":"<p><p><i>Citrobacter koseri</i> is a rarely reported ocular pathogen. It may induce severe peripheral corneal inflammation and subsequent perforation by canaliculitis. Timely detection of the reservoir of this pathogen would halt its progression. The purpose of this study was to report a rare presentation of <i>C. koseri</i> chronic canaliculitis complicated with perforating peripheral ulcerative keratitis (PUK). A 71-year-old female who had several episodes of <i>C. koseri</i> conjunctivitis in the past 6 months was admitted to our infection ward under the impression of fever that was suspected to be related to urinary tract infection. She had concurrent copious mucopurulent discharge and blurred vision. Ocular examination disclosed hyperemic conjunctiva and an oval-shaped corneal infiltrate at 5-6 o'c periphery, which later rapidly progressed to PUK and corneal perforation. Despite aggressive treatment, the cornea continued to thin, and a second perforation occurred. After meticulous examination of the ocular adnexa, irrigation of inferior canaliculi revealed pustular discharge with profuse concretions indicating chronic canaliculitis. A cutaneous-lacrimal fistula was also found. Frequent antibiotic irrigation of the canaliculus finally halted the corneal melting and the cornea healed. Although rare, <i>C. koseri</i> may not only cause chronic canaliculitis but also induce peripheral corneal inflammation mimicking autoimmune-related PUK. Identification of <i>C. koseri</i> from conjunctival swab cultures should prompt the physicians to check chronic persistent canaliculus infections, which may help prevent rapidly progressive corneal inflammation and thus perforation. Management of <i>C. koseri</i> canaliculitis-induced PUK must also include antibiotic irrigation to eradicate canaliculitis infection at the reservoir and not just topical antibiotics.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 1","pages":"376-379"},"PeriodicalIF":1.1,"publicationDate":"2023-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42194383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of big data in ophthalmology. 大数据在眼科中的应用。
IF 1.1 Q4 OPHTHALMOLOGY Pub Date : 2023-04-01 DOI: 10.4103/tjo.TJO-D-23-00012
Zhi Da Soh, Ching-Yu Cheng

The advents of information technologies have led to the creation of ever-larger datasets. Also known as big data, these large datasets are characterized by its volume, variety, velocity, veracity, and value. More importantly, big data has the potential to expand traditional research capabilities, inform clinical practice based on real-world data, and improve the health system and service delivery. This review first identified the different sources of big data in ophthalmology, including electronic medical records, data registries, research consortia, administrative databases, and biobanks. Then, we provided an in-depth look at how big data analytics have been applied in ophthalmology for disease surveillance, and evaluation on disease associations, detection, management, and prognostication. Finally, we discussed the challenges involved in big data analytics, such as data suitability and quality, data security, and analytical methodologies.

信息技术的出现导致了越来越大的数据集的产生。这些大型数据集也被称为大数据,其特点是其数量、种类、速度、准确性和价值。更重要的是,大数据有潜力扩展传统的研究能力,根据真实世界的数据为临床实践提供信息,并改善卫生系统和服务提供。本综述首先确定了眼科大数据的不同来源,包括电子病历、数据登记、研究联盟、管理数据库和生物银行。然后,我们深入探讨了大数据分析如何应用于眼科疾病监测、疾病关联评估、检测、管理和预测。最后,我们讨论了大数据分析所面临的挑战,如数据适用性和质量、数据安全性和分析方法。
{"title":"Application of big data in ophthalmology.","authors":"Zhi Da Soh,&nbsp;Ching-Yu Cheng","doi":"10.4103/tjo.TJO-D-23-00012","DOIUrl":"https://doi.org/10.4103/tjo.TJO-D-23-00012","url":null,"abstract":"<p><p>The advents of information technologies have led to the creation of ever-larger datasets. Also known as <i>big data</i>, these large datasets are characterized by its volume, variety, velocity, veracity, and value. More importantly, big data has the potential to expand traditional research capabilities, inform clinical practice based on real-world data, and improve the health system and service delivery. This review first identified the different sources of big data in ophthalmology, including electronic medical records, data registries, research consortia, administrative databases, and biobanks. Then, we provided an in-depth look at how big data analytics have been applied in ophthalmology for disease surveillance, and evaluation on disease associations, detection, management, and prognostication. Finally, we discussed the challenges involved in big data analytics, such as data suitability and quality, data security, and analytical methodologies.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 2","pages":"123-132"},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5a/06/TJO-13-123.PMC10361443.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9855538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Use of artificial intelligence in forecasting glaucoma progression. 人工智能在青光眼进展预测中的应用。
IF 1.1 Q4 OPHTHALMOLOGY Pub Date : 2023-04-01 DOI: 10.4103/tjo.TJO-D-23-00022
Sahil Thakur, Linh Le Dinh, Raghavan Lavanya, Ten Cheer Quek, Yong Liu, Ching-Yu Cheng

Artificial intelligence (AI) has been widely used in ophthalmology for disease detection and monitoring progression. For glaucoma research, AI has been used to understand progression patterns and forecast disease trajectory based on analysis of clinical and imaging data. Techniques such as machine learning, natural language processing, and deep learning have been employed for this purpose. The results from studies using AI for forecasting glaucoma progression however vary considerably due to dataset constraints, lack of a standard progression definition and differences in methodology and approach. While glaucoma detection and screening have been the focus of most research that has been published in the last few years, in this narrative review we focus on studies that specifically address glaucoma progression. We also summarize the current evidence, highlight studies that have translational potential, and provide suggestions on how future research that addresses glaucoma progression can be improved.

人工智能(AI)已广泛应用于眼科疾病检测和监测进展。在青光眼研究中,人工智能已被用于了解青光眼的进展模式,并根据临床和影像学数据分析预测疾病轨迹。机器学习、自然语言处理和深度学习等技术已被用于此目的。然而,由于数据集的限制、缺乏标准的进展定义以及方法和方法的差异,使用人工智能预测青光眼进展的研究结果差异很大。虽然青光眼的检测和筛查一直是过去几年发表的大多数研究的重点,但在这篇叙述性综述中,我们关注的是专门针对青光眼进展的研究。我们还总结了目前的证据,强调了具有转化潜力的研究,并就如何改进青光眼进展的未来研究提出了建议。
{"title":"Use of artificial intelligence in forecasting glaucoma progression.","authors":"Sahil Thakur,&nbsp;Linh Le Dinh,&nbsp;Raghavan Lavanya,&nbsp;Ten Cheer Quek,&nbsp;Yong Liu,&nbsp;Ching-Yu Cheng","doi":"10.4103/tjo.TJO-D-23-00022","DOIUrl":"https://doi.org/10.4103/tjo.TJO-D-23-00022","url":null,"abstract":"<p><p>Artificial intelligence (AI) has been widely used in ophthalmology for disease detection and monitoring progression. For glaucoma research, AI has been used to understand progression patterns and forecast disease trajectory based on analysis of clinical and imaging data. Techniques such as machine learning, natural language processing, and deep learning have been employed for this purpose. The results from studies using AI for forecasting glaucoma progression however vary considerably due to dataset constraints, lack of a standard progression definition and differences in methodology and approach. While glaucoma detection and screening have been the focus of most research that has been published in the last few years, in this narrative review we focus on studies that specifically address glaucoma progression. We also summarize the current evidence, highlight studies that have translational potential, and provide suggestions on how future research that addresses glaucoma progression can be improved.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 2","pages":"168-183"},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a3/0f/TJO-13-168.PMC10361424.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9861982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Myopia control utilizing low-dose atropine as an isolated therapy or in combination with other optical measures: A retrospective cohort study. 使用低剂量阿托品作为单独治疗或联合其他光学措施控制近视:一项回顾性队列研究。
IF 1.1 Q4 OPHTHALMOLOGY Pub Date : 2023-04-01 DOI: 10.4103/tjo.tjo_31_22
Nir Erdinest, Naomi London, Itay Lavy, Nadav Levinger, Eran Pras, Yair Morad

Purpose: To assess the additive potency of low-dose atropine combined with optical measures designed to decrease myopia progression.

Materials and methods: This retrospective study included 104 myopic children aged 5-12 over 4 years, divided into five groups: daily instillation of 0.01% atropine and distance single-vision spectacles (A), 0.01% atropine and progressive addition lenses (A + PAL), 0.01% atropine and soft contact lens with peripheral blur (A + CL). Two control groups were included, prescribed bifocal spectacles or single vision (SV) spectacles. Cycloplegic spherical equivalence refraction was measured biannually, including 1 year after cessation of treatment.

Results: A significant decrease in myopia progression was noted during the 2nd and 3rd years of atropine treatment: A -0.55 ± 0.55D, -0.15 ± 0.15, -0.12 ± 0.12D were 1st, 2nd, 3rd years, respectively, A + PAL -0.47 ± 0.37D, -0.10 ± 0.25D, and -0.11 ± 0.25D were 1st, 2nd, 3rd years, respectively, A + CL -0.36 ± 0.43D, -0.13 ± 0.29D, and -0.10 ± 0.27D were 1st, 2nd, 3rd years, respectively. Myopia progression over 3 years, respectively, was -0.82 ± 0.50D, -0.70 ± 0.69D, -0.59 ± 0.66D in the bifocal group and -1.20 ± 1.28D, -0.72 ± 0.62D, -0.65 ± 0.47D in the SV group. One year after cessation of atropine treatment, myopia progression was - 0.32 ± 0.31D in A, -0.23 ± 0.28D in A + PAL, and -0.18 ± 0.35D in A + CL.

Conclusion: Atropine 0.01% presented as effective at decelerating myopia progression, more prominent in the 2nd and 3rd years of treatment. Combining atropine 0.01% with optical modalities exhibited a trend for added efficacy over monotherapy. A + CL exhibited the least rebound effect 1 year after cessation of treatment.

目的:评价低剂量阿托品联合光学措施降低近视进展的加性效价。材料与方法:回顾性研究104例5-12岁的4岁以上近视儿童,将其分为每日滴注0.01%阿托品加远距单视眼镜(A)、0.01%阿托品加渐进镜片(A + PAL)、0.01%阿托品加周围模糊软性隐形眼镜(A + CL) 5组。包括两个对照组,处方双焦点眼镜或单视力(SV)眼镜。每半年测量一次睫状体麻痹的球等效屈光度,包括停止治疗后1年。结果:在阿托品治疗的第2年和第3年,近视进展明显降低:A -0.55±0.55D, -0.15±0.15,-0.12±0.12D分别为第1、2、3年,A + PAL分别为-0.47±0.37D, -0.10±0.25D, -0.11±0.25D, A + CL分别为-0.36±0.43D, -0.13±0.29D, -0.10±0.27D分别为第1、2、3年。双焦点组3年近视进展分别为-0.82±0.50D、-0.70±0.69D、-0.59±0.66D, SV组3年近视进展分别为-1.20±1.28D、-0.72±0.62D、-0.65±0.47D。停止阿托品治疗1年后,A组近视进展为- 0.32±0.31D, A + PAL组为-0.23±0.28D, A + CL组为-0.18±0.35D。结论:0.01%阿托品具有明显的减缓近视进展的作用,在治疗第2年和第3年更为显著。0.01%阿托品联合光学治疗比单药治疗有增加疗效的趋势。A + CL在停药1年后反弹效应最小。
{"title":"Myopia control utilizing low-dose atropine as an isolated therapy or in combination with other optical measures: A retrospective cohort study.","authors":"Nir Erdinest,&nbsp;Naomi London,&nbsp;Itay Lavy,&nbsp;Nadav Levinger,&nbsp;Eran Pras,&nbsp;Yair Morad","doi":"10.4103/tjo.tjo_31_22","DOIUrl":"https://doi.org/10.4103/tjo.tjo_31_22","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the additive potency of low-dose atropine combined with optical measures designed to decrease myopia progression.</p><p><strong>Materials and methods: </strong>This retrospective study included 104 myopic children aged 5-12 over 4 years, divided into five groups: daily instillation of 0.01% atropine and distance single-vision spectacles (A), 0.01% atropine and progressive addition lenses (A + PAL), 0.01% atropine and soft contact lens with peripheral blur (A + CL). Two control groups were included, prescribed bifocal spectacles or single vision (SV) spectacles. Cycloplegic spherical equivalence refraction was measured biannually, including 1 year after cessation of treatment.</p><p><strong>Results: </strong>A significant decrease in myopia progression was noted during the 2<sup>nd</sup> and 3<sup>rd</sup> years of atropine treatment: A -0.55 ± 0.55D, -0.15 ± 0.15, -0.12 ± 0.12D were 1<sup>st</sup>, 2<sup>nd</sup>, 3<sup>rd</sup> years, respectively, A + PAL -0.47 ± 0.37D, -0.10 ± 0.25D, and -0.11 ± 0.25D were 1<sup>st</sup>, 2<sup>nd</sup>, 3<sup>rd</sup> years, respectively, A + CL -0.36 ± 0.43D, -0.13 ± 0.29D, and -0.10 ± 0.27D were 1<sup>st</sup>, 2<sup>nd</sup>, 3<sup>rd</sup> years, respectively. Myopia progression over 3 years, respectively, was -0.82 ± 0.50D, -0.70 ± 0.69D, -0.59 ± 0.66D in the bifocal group and -1.20 ± 1.28D, -0.72 ± 0.62D, -0.65 ± 0.47D in the SV group. One year after cessation of atropine treatment, myopia progression was - 0.32 ± 0.31D in A, -0.23 ± 0.28D in A + PAL, and -0.18 ± 0.35D in A + CL.</p><p><strong>Conclusion: </strong>Atropine 0.01% presented as effective at decelerating myopia progression, more prominent in the 2<sup>nd</sup> and 3<sup>rd</sup> years of treatment. Combining atropine 0.01% with optical modalities exhibited a trend for added efficacy over monotherapy. A + CL exhibited the least rebound effect 1 year after cessation of treatment.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 2","pages":"231-237"},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/de/51/TJO-13-231.PMC10361442.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9855536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Taiwan Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1